Get started
3M3M3M

3M

No trades
See on Supercharts
Overview News
Ideas
Discussions Seasonals

MMM trade ideas

MMM - Bellweather, No one Rings the BellIn_Flay_Shun Trade BY the Numbers Revenue 8.95B 24.72% Net income 1.52B 16.69% Diluted EPS 2.59 15.11% Net profit margin 17.03% 6.43% Operating income 2.05B 47.45% Net change in cash 59M 273.53% Cash on hand 4.7B 11.28% Cost of revenue 4.72B 24.02% MMM Cashing UP Reserves Operating Margin Squeeze NET EPS Down COSTS UP 24%.... Bonds will not appreciate the Industrials sending LARGE WARNINGS __________________________________________________________ Murder by Numbers - www.youtube.com
NYSE:MMM
by HK_L61
3M | Fundamental Analysis | Must Read...Industrial giant 3M will publish its Q3 earnings on Oct. 26. As always, quarterly earnings reports help shape investor thinking, whether it's near-term or long-term. Unfortunately, 3M management isn't likely to give investors much good news regarding near-term trends, but what about the long-term outlook? Here's what you should know before the earnings report comes out. The case for buying 3M is based on the idea that the significant free cash flow (FCF) generated by the company will give management the time and strength to turn around some of the volatile performance of recent years. Furthermore, based on that very FCF, the stock looks very favorable. If the company reaches Wall Street's consensus FCF forecast of $5.7 billion in 2021, it will trade at 18.2 times its FCF (current market capitalization is $104 billion). That's a pretty reasonable valuation for a mature industrial business proficient in increasing revenues at a rate not exceeding a single digit (in line with economic growth). If you add some margin expansion to this, and investors can expect a mix of stable earnings growth and dividend growth (current yield is 3.3%), then 3M is an excellent value investment option. However, the question is, where is 3M's profit margin headed? Gross profit margin (profit after cost of goods) is one of the best ways to measure a company's pricing power in the marketplace. While earnings margin before interest, taxes, depreciation, and amortization (EBITDA) also includes operating expenses and is a great way to measure how well a company is managed. 3M's performance has been questionable in recent years, and this is not due to the COVID-19 pandemic. In short, 3M needs to persuade investors that it can return the company to a long-term uptrend in margins. To that end, CEO Mike Roman restructured the business. The company is now managed from four operating segments rather than five, and business groups are now managed globally rather than by country. At the same time, management has undertaken restructuring expenses to streamline its operations. Moreover, management has invested in digital capabilities. The poorly performing healthcare segment has been restructured through divestitures and acquisitions, such as the $6.7 billion purchase of Acelity, a trauma business, and M*Modal, a $1 billion health information systems business; both deals were completed in 2019. So investors are right to sit back and say, "Show me margin expansion." But unfortunately, the COVID-19 pandemic has struck, and its distorting effects have made it much harder to see improvement, especially in terms of margin performance. Moreover, it is difficult to compare similar performance when the economy enters a period of downtime and resumption is impacted by soaring commodity prices and supply chain problems in key end markets. Moreover, many of the problems associated with resumption have worsened in 2021. As a result, the critical data most investors will be watching relates to the ratio of 3M's price to its cost of production. This is a critical metric for investors because 3M management prides itself on investing in innovation to produce differentiated products - in other words, products with pricing power. The dispute over whether 3M products are losing or gaining pricing power won't be resolved during the next earnings report, but we do know that pressure is building because of rising raw material costs and difficulties in the supply chain. For instance, CFO Monish Patolawala projected a $0 to $0.10 decline in earnings per share at the beginning of the year due to rising raw material prices. He later raised that forecast to $0.20, then to $0.30-$0.50 in April, and then to $0.65-$0.80 in July. Moving on to the Morgan Stanley Laguna Conference in mid-September, and Patolawala guided investors to the high end of the range. And that's without taking into account the impact on the supply chain of plant shutdowns during Hurricane Ida. Patolawala also said that inflation is outpacing 3M's ability to raise prices, and noted that auto production (a key end market for 3M) will be weaker than originally expected. In addition, the health care recovery has been uneven and the number of fee-for-service procedures is below management expectations, semiconductor shortages have impacted consumer electronics, and office resumption (3M sells office supplies) has been delayed. All point to a troubled earnings report. Still, much of the bad news should already be priced in, so don't be surprised if 3M stock rises if management's recommendations and comments turn out not to be so bad. Still, the earnings report is unlikely to do much good for long-term investors who are looking for convincing evidence that the turnaround attempts are working. Thus, 3M is likely to remain a good value stock, but with doubts surrounding it.
NYSE:MMMLong
by FOREXN1
1
Purchase of 3M in the continuation of the 5th wave of growthThe company is 3M (MMM). According to all estimates and proportions, now the price in 3M is in the 4th wave in the form of a triangle. The price is at the lower border of the triangle, there have already been false takeaways down. I propose to consider buying it in the continuation of the 5th wave with the goal of expanding on the first wave of Fibonacci 2.618, or 0.618 from the third wave. These Fibonacci levels coincide with the global maximum of January 2018, which also confirms their validity. The potential yield from the current price is 32 percent with the prospect of growth for about a year. Naturally , this is not an investment recommendation.
NYSE:MMMLong
by rvasilchenko
MMM - 3M COMPANY - upside break Historic: 08/27/2021 (dd-mm-yy) Fear & Greed Index: 39 Mid-term forecast (2-4 weeks): If price breaks the 208.80 resistance, a resumption of a strong uptrend is expected. Aiming at 222.07 (2-3 weeks) and 280.61 (3-4 weeks). If the support at 187.63 breaks, the short-term forecast (resumption of the downtrend) will not be valid. We will close our open trades if the 187 or 122.16 level is broken in the medium term. Technical analysis: A CUP forms on the daily chart between 200 and 121, starting on april 01, 2019. This week in August 27, 2021 it can break 208.80 and is expected to rise to 222.07 and 280.61 according to technical analysis and confirmation of the pattern. + Trigger: Trigger1= 208.80 + Take Profits: TP1=222.07 TP2=280.61 + Stop: Stop1=187.63 Stop2=122.16 ❤️ If you find this helpful and want more FREE forecasts in TradingView . . . . . Please show your support back, . . . . . . . . Hit the 👍 LIKE button, . . . . . . . . . . Drop some feedback below in the comment!
NYSE:MMMLong
by LimitlessNautilus
Trade Setup: Buy/Long 3M CompanyType: Swing On Tuesday 27 July, the company reported their quarterly results, with both earnings and revenue exceeding expectations, with net income of $1.524 billion, or $2.59 a share, in the second quarter, up from $1.306 billion, or $2.25 a share, in the year-earlier period. Adjusted per-share earnings were also $2.59, ahead of the $2.28 FactSet consensus. In addition, the company raised it's full-year guidance with as it now expects full-year sales to grow 7% to 10%, up from prior guidance of 5% to 8%. It also expects per-share earnings to range from $9.70 to $10.10, against prior guidance of $9.20 to $9.70. With the earnings having been reported, traders are now able to take advantage of the potential upward swing in price as market participants latch onto the results. A review of the daily chart sees the price looking to emerging from a 3-month consolidation range to continue it's gradual upward trend. The downward trend line extending back to the peak of 10 May is being cleared while the pivot is also being held. We also note the 7-day RSI trading at 63 (and clearing the downward trend line), which is considered a strong rank. In addition, the 50-day EMA is being reclaimed Trade Levels: Buy at current levels or better ($201.57 or lower) Stop-loss: $196.15 Target: $212.00
NYSE:MMMLong
by LD_Perspectives